
Financial Year Overview
A particularely challenging year
The year 2025 continued its downward trend in the Luxury division stronger as expected but we could report a positive progress in Medtech division and a rebound in Industry division. The Dental Brand sales were negatively impacted by the increase in precious metal prices, the US tariffs and the liquidation of its subsidiaries.
Key figures 2025
Net sales
mCHF 232.1
+3.2% vs. 2024
Net sales excl. precious metal
mCHF 125.9
+15.2% vs. 2024
EBITDA (reported)
mCHF 51.6
+132.0% vs. 2024
EBITDA (operational)
mCHF 21.7
-2.5% vs. 2024
Investor relations
Governance and Shareholder Information
Next General Assembly
Thursday, May 7th – Biel/Bienne
The invitation and agenda will be published on this page 30 days prior to the meeting.
Other information and Downloads
Financial Reports
Governance
Shareholder Services
CMSA Group










